StayAlert Results:
Search results for: "fda"
336 results (showing 1 through 25)
The US Food and Drug Administration (FDA) has reviewed the final results from the post-approval study conducted by SynCardia Systems for their Temporary ...
The US Food and Drug Administration (FDA) has launched a new Medication Guide database ...
Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety ...
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2018 Medical Product Safety Alert.
The FDA has updated the list of valsartan products under recall (https://www.fda. gov/downloads/Drugs/DrugSafety/UCM615703.pdf) and the list of valsartan ...
The FDA has classified this as a Class I recall. Vyaire has received no complaints of this problem; there have been no patient injuries. Recalled Product(s): ...
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2018 Medical Product Safety Alert.
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled product details: ...
The US Food and Drug Administration (FDA) is reminding health care providers that tests to detect rupture of the amniotic membranes should not be used ...
The US Food and Drug Administration (FDA) is warning health care providers that the antibiotic Zithromax, Zmax (azithromycin,) should not be given long-term to ...
In the United States, it is not approved by the Food and Drug Administration (FDA ) for medical use, however, it is readily available for purchase online as a ...
... of this product may be reported to FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2018 Medical Product Safety Alert.
The US Food and Drug Administration (FDA) is updating health care professionals and patients after discovering that several additional companies that ...
The US Food and Drug Administration (FDA) is alerting patients and health care providers that the use of energy-based devices to perform vaginal "rejuvenation ...
These concerns arose following a routine inspection of the pharmacy by FDA. Administration of a non-sterile product that is intended to be sterile by ...
The US Food and Drug Administration (FDA) recently announced the approval of TPOXX, the first drug with an indication for treatment of Smallpox. Though the ...
In January 2018, the FDA issued a Safety Communication (https://www.fda.gov/ MedicalDevices/Safety/AlertsandNotices/ucm592583.htm) alerting patients and ...
The US Food and Drug Administration (FDA) released an update for healthcare professionals and consumers on the agency's progress in responding to the ...
The US Food and Drug Administration (FDA) is alerting health care professionals to risks associated with Cesium chloride (CsCl), a mineral salt that is ...
... MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Resources: * External Links * FDA 2018 Medical Product Safety Alerts.
The US Food and Drug Administration (FDA) is alerting health care professionals and patients of a voluntary recall of several drug products containing the active ...
The US Food and Drug Administration (FDA) is strengthening the current warnings in the prescribing information for fluoroquinolone antibiotics to reflect the ...
The US Food and Drug Administration (FDA) is alerting health care professionals and patients, as well as veterinarians and animal owners, not to use human ...
The revised guidance explains the basis for the FDA's determination that pooled testing of donations using a screening test licensed for such use by the FDA is a ...
... this product may be reported to the FDA's MedWatch Adverse Event Reporting program. Resources: * External Links * FDA 2018 Medical Product Safety Alert.
Previous Page Next Page